39例原发性输卵管癌临床病理分析

doi:10.11904/j.issn.1002-3070.2017.04.009

摘要/Abstract

摘要： 目的探讨原发性输卵管癌(PFTC)的临床病理特点及合理的治疗方法。方法回顾性研究2006年1月—2016年7月首都医科大学附属北京同仁医院收治的39例原发性输卵管癌患者的临床病理资料并进行分析。结果手术病理结果39例,其中未分化癌1例、未分化及移行细胞癌1例、腺癌37例;单纯型腺癌29例、混合型10例,其中合并透明细胞癌7例,合并子宫内膜样癌2例,合并移行细胞癌1例。盆腔外转移最常见的部位是大网膜,为17例,术前化验CA125升高13例,38例患者接受术后化疗,39例患者5年总存活率为51.3%。单因素分析显示:术后病理分期(Ⅰ~Ⅱ vs.Ⅲ,P＜0.001)、术中残存灶大小(P＜0.001)、大网膜转移(P＜0.001)、卵巢转移(P=0.034)、腹膜后淋巴结转移(P=0.018)及术前CA125升高(P=0.002)与预后相关,而年龄(P=0.310)及病理分级(P=0.663)与预后不相关,多因素分析显示大网膜转移(HR=12.205,95%CI:2.354~63.290,P=0.003)及病理分期(HR=3.810,95%CI:1.202~12.079,P=0.023)与预后有关,为独立预后因素。结论肿瘤病理分期和大网膜转移是影响原发性输卵管癌患者预后的重要因素,早期诊断彻底手术可改善患者预后。

关键词: 原发性输卵管癌, 大网膜转移, CA125抗原, 危险因素

Abstract: Objective The objective of this study was to investigate the clinicopathological features and rational treatment of primary fallopian tube cancer(PFTC).Methods The clinical and pathological data of 39 patients with primary fallopian tube cancer from January 2006 to July 2016 in Beijing Tongren Hospital of Capital University were retrospectively analyzed.Results There were 39 cases of undifferentiated carcinoma,including 1 case of undifferentiated and transitional cell carcinoma,37 cases of undifferentiated adenocarcinoma,or 29 cases of simple adenocarcinoma and 10 cases of mixed type.Among them,7 cases were treated with clear cell carcinoma,endometriosis in 2 cases,combined with transitional cell carcinoma in 1 case.Extra-pelvic metastases were the most common site of the omentum with 17 cases.The preoperative test CA125 was increased in 13 cases and 38 patients received postoperative chemotherapy.The 5-year overall survival rate of 39 patients was 51.3%.Univariate analysis showed that postoperative pathologic stage(Ⅰ~Ⅱ vs.Ⅲ,P＜0.001),intraoperative residual lesion size(P＜0.001),omentum metastasis(P＜0.001),ovarian metastasis(P=0.034),retroperitoneal lymph node metastasis(P=0.018)and preoperative CA125 elevation(P=0.002)were associated with prognosis,while age(P=0.310)and pathological grade(P=0.663)were not associated with prognosis.Multivariate analysis showed that the number of patients with postoperative lymph node metastasis(P=0.018)and preoperative CA125 elevation(P=0.002)were correlated with prognosis(HR=1.202,95% CI:2.354~63.290,P=0.003) and pathological stage(HR=3.810,95% CI:1.202~12.079,P=0.023).They were associated with prognosis as independent prognostic factors.Conclusion Tumor pathologic staging and omentum metastasis are important prognostic factors influencing the prognosis of patients with primary fallopian tube cancer.Early diagnosis and complete operation can improve the prognosis of patients.

Key words: Primary fallopian tube carcinoma, Greater omentum metastasis, CA125 antigen, Risk factors

中图分类号:

R737.3

倪成香,闻静,初幸之,许禅,翟建军. 39例原发性输卵管癌临床病理分析[J]. 实用肿瘤学杂志, 2017, 31(4): 335-341.

NI Chengxiang,WEN Jing,CHU Xingzhi,XU Chan,ZHAI Jianjun. Clinicopathological analysis of 39 cases with primary fallopian tube cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(4): 335-341.

参考文献

1 Liu L,Xu X,Jia L,et al.Primary fallopian tube carcinoma-a retrospective analysis of 66 cases[J].Eur J Gynaecol Oncol,2015,36(2):161-167.
2 Nanaiah SP,Rathod PS,Rajkumar NN,et al.Primary carcinoma of the fallopian tube:a review of a single institution experience of 8 cases[J].Scientific World Journal,2014,2014:630731.
3 Oliveira C,Duarte H,Bartosch C,et al.Small fallopian tube carcinoma with extensive upper abdominal dissemination:a case report[J].J Med Case Rep,2013,7:252.
4 Ou YC,Huang HY,Huang CC,et al.Primary fallopian tube carcinoma:clinicopathological analysis of 12 cases[J].Taiwan J Obstet Gynecol,2011,50(2):141-144.
5 Pectasides D,Pectasides E,Papaxoinis G,et al.Primary fallopian tube carcinoma:results of a retrospective analysis of 64 patients[J].Gynecol Oncol,2009,115(1):97-101.
6 Polcher M,Zivanovic O,Chi DS.Cytoreductive surgery for advanced ovarian cancer[J].Womens Health(Lond),2014,10(2):179-190.
7 Coleman RL,Duska LR,Ramirez PT,et al.Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian,primary peritoneal,or fallopian tube cancer[J].Lancet Oncol,2011,12(12):1109-1117.
8 Rabban JT,Barnes M,Chen LM,et al.Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations,emphasizing the differential diagnosis of occult primary and metastatic carcinoma[J].Am J Surg Pathol,2009,33(8):1125-1136.
9 Riska A,Leminen A.Updating on primary fallopian tube carcinoma[J].Acta Obstet Gynecol Scand,2007,86(12):1419-1426.
10 Salvador S,Gilks B,Kobel M,et al.The fallopian tube:primary site of most pelvic high-grade serous carcinomas[J].Int J Gynecol Cancer,2009,19(1):58-64.
11 Horng HC,Teng SW,Huang BS,et al.Primary fallopian tube cancer:domestic data and up-to-date review[J].Taiwan J Obstet Gynecol,2014,53(3):287-292.
12 Monge AH,Pineda RP,del Rocio Estrada Hernandez M,et al.Fallopian tube primary invasive adenocarcinoma associated with acute inflammatory pelvic disease.Case report and literature review[J].Ginecol Obstet Mex,2008,76(2):118-124.
13 Litta P,Codroma A,Borghero A,et al.Primary tubal carcinoma[J].J Minim Invasive Gynecol,2013,20(6):739-740.
14 Hefler LA,Rosen AC,Graf AH,et al.The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma:a multicenter study[J].Cancer,2000,89(7):1555-1560.
15 Colakovic S,Lukic V,Mitrovic L,et al.Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer[J].Int J Biol Markers,2000,15(2):147-152.
16 Ma FH,Cai SQ,Qiang JW,et al.MRI for differentiating primary fallopian tube carcinoma from epithelial ovarian cancer[J].J Magn Reson Imaging,2015,42(1):42-47.
17 Ma Y,Duan W.Clinical and survival analysis of 36 cases of primary fallopian tube carcinoma[J].World J Surg Oncol,2014,12:311.
18 Malmberg K,Klynning C,Floter-Radestad A,et al.Serous tubal intraepithelial carcinoma,chronic fallopian tube injury,and serous carcinoma development[J].Virchows Arch,2016,468(6):707-713.

[1]	刘帛岩, 晏阳, 陈玉辉, 胡时栋, 杨宇, 李松岩. 完全腹腔镜右半结肠切除术联合腹腔热灌注化疗后延迟性肠麻痹危险因素分析与风险预测模型构建[J]. 实用肿瘤学杂志, 2023, 37(6): 472-477.
[2]	陈飞, 王颖, 曾传琴. B7-H4在乳腺癌组织中的表达及其与患者新辅助化疗后腋窝淋巴结转移的相关性分析[J]. 实用肿瘤学杂志, 2023, 37(4): 360-366.
[3]	张馨, 吴羡美, 李虹, 刘晓舟, 孔德文, 陈琢. 1990—2019年中国女性人群归因于代谢危险因素的乳腺癌疾病负担[J]. 实用肿瘤学杂志, 2023, 37(2): 107-111.
[4]	徐伟, 刘海鹏, 汪文杰, 王舟, 李元元, 沈亦敏, 陈晓. 胃癌术后胆囊结石形成的危险因素及预防措施的研究进展[J]. 实用肿瘤学杂志, 2022, 36(6): 561-565.
[5]	张浩, 杨新官, 何涌. 肌少症与晚期非小细胞肺癌临床病理特征及预后的相关性分析[J]. 实用肿瘤学杂志, 2022, 36(3): 214-219.
[6]	李健, 马麒, 任瑾, 呼圣娟. 胃癌影响因素研究进展[J]. 实用肿瘤学杂志, 2020, 34(5): 466-470.
[7]	阚钧, 周岱翰综述, 张恩欣审校. 肿瘤合并心血管疾病的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 558-561.
[8]	万静萱, 李红红, 周湘乡, 马琳. Ⅳ期肺癌合并肺血栓栓塞的危险因素分析[J]. 实用肿瘤学杂志, 2018, 32(3): 214-244.
[9]	廖先珍, 颜仕鹏, 石菊芳, 石朝晖, 邹艳花, 肖海帆, 许可葵, 朱松林. 城市女性乳腺癌高危评估及筛查结果分析[J]. 实用肿瘤学杂志, 2016, 30(3): 245-248.
[10]	刘春勋, 孙建民, 张玉宝, 赵红伟. 肝癌微波治疗术对患者肾功能影响因素的分析[J]. 实用肿瘤学杂志, 2015, 29(3): 212-215.
[11]	秦艳娟, 丁婷. 超声介入瘤内注射无水酒精治疗原发性肝癌近期复发危险因素[J]. 实用肿瘤学杂志, 2015, 29(3): 216-220.
[12]	张新宇,王乐综述,张清媛审校. 三阴性乳腺癌易患因素的研究进展[J]. 实用肿瘤学杂志, 2014, 28(5): 477-480.
[13]	张建锋, 武雪亮, 王贵英, 周超熙, 牛文博, 席金川. 结肠癌D3清扫术后乳糜漏的危险因素分析[J]. 实用肿瘤学杂志, 2013, 27(4): 323-327.
[14]	高岩,姚文庆,王硕. 沈阳市子宫颈癌发病危险因素的病例对照研究[J]. 实用肿瘤学杂志, 2013, 27(2): 130-132.
[15]	阎素红, 赵长宏孙立春. 青年女性肺癌危险因素及临床特征分析[J]. 实用肿瘤学杂志, 2011, 25(2): 179-182.